Page last updated: 2024-10-28

hydroxychloroquine and Osteogenic Sarcoma

hydroxychloroquine has been researched along with Osteogenic Sarcoma in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gustafson, DL1
Viola, LO1
Towers, CG1
Das, S1
Duval, DL1
Van Eaton, KM1
O'Farrill, JS1
Gordon, N1

Reviews

1 review available for hydroxychloroquine and Osteogenic Sarcoma

ArticleYear
Autophagy in osteosarcoma.
    Advances in experimental medicine and biology, 2014, Volume: 804

    Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Bone and Bones; Bone Neoplasms; Cell Line, Tumo

2014

Other Studies

1 other study available for hydroxychloroquine and Osteogenic Sarcoma

ArticleYear
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.
    Veterinary and comparative oncology, 2023, Volume: 21, Issue:4

    Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Dog Diseases; Dogs; Humans; Hydroxychlo

2023